Advanced Oncotherapy launches £2.7m capital raising

Writer,

Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

Proton system for cancer treatment developer Advanced Oncotherapy launched a £2.7m shar issue to fund verification and validation activity to obtain regulatory approval for its technology.

New shares in the company were being offered at 40p each.

At 1:25pm: (LON:AVO) Advanced Oncotherapy PLC share price was +1.5p at 39p